Year-over-year, this metric declined by 46.3%, from $2.85 to $1.53.
Higher values suggest more generous equity compensation packages or higher stock price expectations at the time of grant.
The weighted average fair value at the grant date for equity instruments, excluding options, awarded to employees during...
Standard disclosure in stock-based compensation footnotes for most public companies.
other_share_based_compensation_arrangement_by_share_base_29f1a5| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.77 | $14.15 | $11.84 | $11.06 | $0.00 | $5.04 | $4.81 | $0.00 | $4.78 | $3.06 | $0.00 | $2.85 | $2.54 | $0.00 | $1.53 |
| QoQ Change | — | -4.2% | -16.3% | -6.6% | -100.0% | — | -4.6% | -100.0% | — | -36.0% | -100.0% | — | -10.9% | -100.0% | — |
| YoY Change | — | — | — | -25.1% | -100.0% | -57.4% | -56.5% | — | -5.2% | -36.4% | — | -40.4% | -17.0% | — | -46.3% |